HU9403809D0 - Substituted (arylalkylaminobenzyl)-aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents - Google Patents

Substituted (arylalkylaminobenzyl)-aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents

Info

Publication number
HU9403809D0
HU9403809D0 HU9403809A HU9403809A HU9403809D0 HU 9403809 D0 HU9403809 D0 HU 9403809D0 HU 9403809 A HU9403809 A HU 9403809A HU 9403809 A HU9403809 A HU 9403809A HU 9403809 D0 HU9403809 D0 HU 9403809D0
Authority
HU
Hungary
Prior art keywords
hydrogen
neuroprotective
arylalkylaminobenzyl
epileptic
substituted
Prior art date
Application number
HU9403809A
Other languages
English (en)
Other versions
HUT70944A (en
Inventor
Mario Varasi
Alberto Bonsignori
Philippe Dostert
Paolo Pevarello
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of HU9403809D0 publication Critical patent/HU9403809D0/hu
Publication of HUT70944A publication Critical patent/HUT70944A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9403809A 1993-04-01 1994-03-15 Substituted (arylalkylaminobenzyl)-aminopropionamide derivatives, their preparation and pharmaceutical compns. contg. them with anti-epileptic, neuroprotective and antidepressant activity HUT70944A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939306899A GB9306899D0 (en) 1993-04-01 1993-04-01 Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation

Publications (2)

Publication Number Publication Date
HU9403809D0 true HU9403809D0 (en) 1995-02-28
HUT70944A HUT70944A (en) 1995-11-28

Family

ID=10733226

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9403809A HUT70944A (en) 1993-04-01 1994-03-15 Substituted (arylalkylaminobenzyl)-aminopropionamide derivatives, their preparation and pharmaceutical compns. contg. them with anti-epileptic, neuroprotective and antidepressant activity

Country Status (21)

Country Link
US (1) US5449692A (hu)
EP (1) EP0648202B1 (hu)
JP (1) JP3542600B2 (hu)
KR (1) KR950701905A (hu)
CN (1) CN1035939C (hu)
AT (1) ATE152442T1 (hu)
AU (1) AU667169B2 (hu)
CA (1) CA2136008C (hu)
DE (1) DE69402935T2 (hu)
DK (1) DK0648202T3 (hu)
ES (1) ES2104370T3 (hu)
FI (1) FI945582A0 (hu)
GB (1) GB9306899D0 (hu)
GR (1) GR3024150T3 (hu)
HU (1) HUT70944A (hu)
IL (1) IL108970A0 (hu)
NZ (1) NZ263183A (hu)
PL (1) PL306538A1 (hu)
RU (1) RU94046144A (hu)
WO (1) WO1994022809A1 (hu)
ZA (1) ZA941964B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9515412D0 (en) * 1995-07-27 1995-09-27 Pharmacia Spa 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives
IT1283489B1 (it) * 1996-07-23 1998-04-21 Chiesi Farma Spa Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
EP2201944B1 (en) 1997-11-21 2012-05-23 Purdue Neuroscience Company Use of substituted 2-aminoacetamides for treating, preventing or ameliorating manic depression
GB9727523D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Alpha-aminoamide derivatives useful as analgesic agents
US6281211B1 (en) 1999-02-04 2001-08-28 Euro-Celtique S.A. Substituted semicarbazides and the use thereof
WO2000061188A1 (en) * 1999-04-09 2000-10-19 Euro-Celtique S.A. Sodium channel blocker compositions and the use thereof
SI1423168T1 (sl) 2001-09-03 2006-06-30 Newron Pharm Spa Farmacevtski sestavek, ki vsebuje gabapentin ali njegov analog in alfa-aminoamid, in njegova analgetska uporaba
EP1438956A1 (en) 2003-01-16 2004-07-21 Newron Pharmaceuticals S.p.A. Alpha-aminoamide derivatives useful as antimigraine agents
JP5319920B2 (ja) * 2004-09-10 2013-10-16 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ナトリウムおよび／またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための（ハロベンジルオキシ）ベンジルアミノ−プロパンアミドの使用
BRPI0617891A2 (pt) * 2005-10-26 2011-08-09 Boehringer Ingelheim Int compostos de (hetero)arila com atividade antagonista de mch, sais fisiologicamente aceitáveis dos mesmos, composição, composição farmacêutica bem como uso e preparação dos ditos compostos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1140748A (en) * 1966-06-23 1969-01-22 Ici Ltd New carboxylic acid derivatives
US4049663A (en) * 1972-06-06 1977-09-20 Allen & Hanburys Limited Ethylene diamine derivatives
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
IL94466A (en) * 1989-05-25 1995-01-24 Erba Carlo Spa Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation

Also Published As

Publication number Publication date
ES2104370T3 (es) 1997-10-01
IL108970A0 (en) 1994-06-24
JPH08504828A (ja) 1996-05-28
EP0648202A1 (en) 1995-04-19
KR950701905A (ko) 1995-05-17
AU6377694A (en) 1994-10-24
HUT70944A (en) 1995-11-28
DK0648202T3 (da) 1997-10-27
EP0648202B1 (en) 1997-05-02
RU94046144A (ru) 1996-09-27
CN1035939C (zh) 1997-09-24
GB9306899D0 (en) 1993-05-26
FI945582A (fi) 1994-11-28
WO1994022809A1 (en) 1994-10-13
US5449692A (en) 1995-09-12
NZ263183A (en) 1996-02-27
JP3542600B2 (ja) 2004-07-14
PL306538A1 (en) 1995-04-03
AU667169B2 (en) 1996-03-07
DE69402935T2 (de) 1997-11-20
CA2136008C (en) 2005-06-14
ATE152442T1 (de) 1997-05-15
CN1104018A (zh) 1995-06-21
GR3024150T3 (en) 1997-10-31
DE69402935D1 (de) 1997-06-05
FI945582A0 (fi) 1994-11-28
CA2136008A1 (en) 1994-10-13
ZA941964B (en) 1994-10-19

Similar Documents

Publication Publication Date Title
ES8105705A1 (es) Un procedimiento para la preparacion de sulfonamidas.
IL108969A0 (en) Substituted (arylalkoxybenzyl) aminopropionamide derivatives, their preparation and pharmaceutical compositions containing them
TW225513B (hu)
GR3024150T3 (en) Substituted (arylalkylaminobenzyl)aminopropionamide derivatives, their preparation and use anti-epileptic, neuroprotective and antidepressant agents.
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
DE69330601D1 (de) Serotoninergische ergolin derivate
DK0581904T3 (da) Fremgangsmåde til inhibering af fibrose
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
TW289019B (hu)

Legal Events

Date Code Title Description
DFC4 Cancellation of temporary protection due to refusal